Hector Sepulveda-Alemany
Cardiovascular Disease · Guaynabo, PRNPI 1427506682
Payments from drug & device makers
Across 127 payments — averaging $43.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$980
- Medtronic$568
- Abbott$429
- Boehringer Ingelheim$426
- E.r. Squibb & Sons, L.L.C.$394
- plus $1K from 9 others
What the payments were for
- Food & beverage$5,21595%
- Education$2725%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 22 | $1,644 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 30 | $980 |
| Medtronic | 8 | $568 |
| Abbott | 4 | $429 |
| Boehringer Ingelheim | 12 | $426 |
| E.r. Squibb & Sons, L.L.C. | 17 | $394 |
| AstraZeneca | 4 | $283 |
| Johnson & Johnson | 7 | $260 |
| PBG Puerto Rico LLC | 6 | $123 |
| Merck | 5 | $107 |
| Bayer Puerto Rico Inc. | 4 | $93 |
| Novartis | 3 | $60 |
| Scpharmaceuticals Inc. | 2 | $49 |
| Amgen | 2 | $42 |
| Dexcom, Inc. | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LifeVest$700
- GENERAL - THERAPIES$272
- GENERAL TACHY$261
- FARXIGA$250
- AVEIR$247
- JARDIANCE$203
- AZURE XT DR MRI SURESCAN$164
- ONYX FRONTIER$155
- EMBLEM S ICD ELECTRODE DELIVERY SYSTEM$111
- GALLANT$110
- GENERAL BRADY$103
- WATCHMAN Access System$100
How this compares
$5,486 in reported general payments places this provider in the 65th percentile of 267 cardiovascular disease providers in Puerto Rico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 17 | $12,528 |
| JardianceEmpagliflozin | 16 | $12,243 |
| BrilintaTicagrelor | 18 | $8,363 |
| Metoprolol Succinate | 13 | $160 |
| Atorvastatin Calcium | 20 | $139 |
| Losartan Potassium | 16 | $115 |
| Warfarin Sodium | 21 | $108 |
| Carvedilol | 14 | $74 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $426 | $12,24316 claims |
| AstraZenecaBrilinta | $283 | $8,36318 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 267 cardiovascular disease providers in Puerto Rico.
Other cardiovascular disease in Guaynabo
- Luis Rodriguez OspinaGuaynabo$365K
- Luis Rosado CarrilloGuaynabo$173K
- Denis Ruiz SerranoGuaynabo$66K
- Jose Reyes PenaGuaynabo$11K
- Karen Rodriguez MaldonadoMayaguez$231K
- Jose NovoaBayamon$209K
- Manuel GuzmanSan Juan$203K
- Jorge GonzalezCaguas$114K
- Rafael Calderon-RodriguezRio Piedras$98K
- Luis GelyCaguas$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.